Skip to main content
. 2018 Mar 16;8(8):213–229. doi: 10.1177/2045125318762373

Table 2.

Univariate analysis for the variables of patient/disease and medication characteristics, patients’ attitude towards medicine use and healthcare-professional-rated assessment.

Variables n % rehospitalized HR (95% CI)
Overall 87 33.3
Patient and disease characteristics
Duration of index hospitalization 0.99 (0.98–1.00)*
Diagnosis of psychotic disorder
 Schizophrenia 34 44.1 Reference
 Schizoaffective disorder 13 23.1 0.49 (0.14–1.71)
 Brief psychotic disorder 18 33.3 0.66 (0.26–1.70)
 Bipolar disorder I 22 22.7 0.44 (0.16–1.20)*
Sex
 Male 52 34.6 Reference
 Female 35 31.4 0.99 (0.47–2.01)
Age (years) 1.02 (0.99–1.05)*
Residential situation
 Alone 40 40.0 Reference
 Living with others 45 26.7 0.62 (0.29–1.31)
 Other/unknown 2 50.0 1.13 (0.15–8.57)
History of substance use
 No 64 34.4 Reference
 Yes 23 30.4 0.82 (0.35–1.92)
First admission
 Yes 9 33.3 Reference
 No 78 33.3 1.03 (0.31–3.40)
GAF score 1.01 (0.98–1.05)
Department at discharge
 Open unit 73 32.9 Reference
 Closed unit 14 35.7 1.01 (0.38–2.64)
Medication characteristics
Number of AP used at discharge+
 One antipsychotic agent 69 36.2 Reference
 ⩾Two antipsychotic agents 18 22.2 0.56 (0.20–1.61)
Type of AP
 First generation 13 30.8 0.72 (0.25–2.06)
 Second generation 65 38.5 Reference
 Combination of both 9 0.0 NA
Number of comedications at discharge 1.03 (0.99–1.15)
Patients themselves picked up medication at community pharmacy
 No 21 19.0 Reference
 Yes 66 37.9 1.45 (0.87–2.39)*
Someone was always available to remind patients to take medication
 Yes 26 15.4 Reference
 No 43 44.2 3.32 (1.13–9.78)**
 Now and then 18 33.3 2.41 (0.68–8.54)*
Somebody else was giving patients their medication when they were not taking it
 Yes 18 22.2 Reference
 No 68 36.8 1.68 (0.59–4.84)
 Unknown 1 0.0 NA
Patients’ attitude towards medication use
Belief groups
 Ambivalent 33 18.2 Reference
 Skeptical 18 50.0 3.38 (1.20–9.50)**
 Indifferent 8 25.0 1.50 (0.30–7.44)
 Accepting 28 42.9 2.62 (0.98–7.00)*
BMQ-general
 Harm score+ 0.92 (0.81–1.04)*
 Overuse score+ 1.02 (0.90–1.15)
Healthcare-professional-rated assessment
Physician asked whether patient was adherent to AP
 Yes 62 37.1 Reference
 No 24 25.0 0.66 (0.27–1.61)
 Do not know anymore 1 0.0
Nurse asked whether patient was adherent to AP
 Yes 64 37.5 Reference
 No 22 22.7 0.58 (0.22–1.52)
 Do not know anymore 1 0.0 NA
Physician discussed AP adherence during admission
 Yes 71 32.4 Reference
 No 15 33.3 1.06 (0.40–2.79)
 Do not know anymore 1 100.0 NA
Nurse discussed AP adherence during admission
 Yes 65 38.5 Reference
 No 21 19.0 0.45 (0.16–1.30)*
 Do not know anymore 1 0.0 NA
Physician predicted patient would use AP after discharge
 Yes 72 37.5 Reference
 No 7 0.0 NA
 I do not know 8 25.0 0.63 (0.15–2.65)
Nurse predicted patient would use AP after discharge
 Yes 73 35.6 Reference
 No 7 42.9 1.28 (0.39–4.22)
 I do not know 7 0.0 NA
AP adherence prediction by physician (%) 1.04 (0.99–1.02)
AP adherence prediction by nurse (%) 1.00 (0.99–1.02)
Rehospitalization prediction by physician (%)
 Prediction ⩽50% 60 35.0 Reference
 Prediction >50% 27 29.6 0.77 (0.34–1.75)
Rehospitalization prediction by nurse (%)
 Prediction ⩽50% 58 25.9 Reference
 Prediction >50% 29 48.3 2.13 (1.03–4.42)**
Therapeutic relationship according to physician
 Good 60 36.7 Reference
 Moderate/bad 27 25.9 0.71 (0.30–1.66)
Therapeutic relationship according to nurse
 Good 63 31.7 Reference
 Moderate/bad 24 37.5 1.18 (0.54–2.59)
*

p < 0.2; **p < 0.05.

+

Continuous variable.

AP, antipsychotics; BMQ, Beliefs about Medicines Questionnaire; CI, confidence interval; GAF, Global Assessment of Functioning scale; HR, hazard ratio; NA, not applicable.